4:3 Fasting: A Consumer Guide

Key Takeaways

• A 2025 randomized trial published in Annals of Internal Medicine found that 4:3 intermittent fasting produced greater weight loss at 12 months compared with daily calorie restriction (PMID 42296520).
• A scoping review found that intermittent fasting generally preserved fat-free mass in middle-aged and older adults, though results varied by protocol and individual factors (PMID 42463249).
• An age-specific meta-analysis found intermittent fasting improved body composition and cardiometabolic markers across adult age groups, with some variation by age (PMID 42280443).
• Researchers are actively studying 4:3 fasting in breast cancer survivors and people with depression, meaning evidence for these groups is still emerging (PMIDs 42492498, 42363285).
• Digital tools such as apps and wearables are increasingly used to support fasting adherence, but their long-term effectiveness is still being evaluated (PMID 42310647).

What exactly is 4:3 intermittent fasting and how does it work?

4:3 intermittent fasting means eating normally four days a week and significantly restricting calories on the other three non-consecutive days. It is a structured eating pattern—not a specific diet—that cycles your body between periods of typical food intake and deliberate, short-term calorie reduction.

Here is how the basic structure works:

• Four "regular" days: You eat your usual meals without strict calorie counting, though healthy food choices are still encouraged.
• Three "fasting" days: You limit calories to roughly 500–600 calories (sometimes called a "very low calorie day"). These days are spread across the week and do not run back-to-back—for example, Monday, Wednesday, and Friday.

The "4:3" refers to that ratio: four regular days to three reduced-calorie days.

Why does this pattern affect weight? On low-calorie days, your body draws on stored energy—primarily body fat—to make up the shortfall. Over time, this creates a meaningful overall calorie deficit across the week without requiring daily restriction. A 12-month clinical trial found that people following a 4:3 intermittent fasting plan lost significantly more weight than those following daily calorie restriction, suggesting the alternating rhythm may offer a practical advantage for some people.

How it differs from other fasting approaches:

Researchers are also studying how intermittent fasting patterns influence metabolic markers such as blood sugar, insulin sensitivity, and body composition—including how much of the weight lost comes from fat versus muscle, which matters especially for older adults, according to a scoping review on fat-free mass.

For people using GLP-1 medications, the 4:3 pattern can complement their effects by adding a structured, time-limited layer of calorie reduction—without requiring daily restriction throughout the week.

---

This content is for general informational purposes only and is not a substitute for personalized medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional before starting any fasting program, especially if you are taking prescription medications.

What does the research say about weight loss with 4:3 fasting?

Research shows that 4:3 intermittent fasting — eating normally four days a week and significantly restricting calories on the other three — produces meaningful weight loss. A large 2025 clinical trial found it outperformed daily calorie cutting at the 12-month mark.

The headline finding

A key clinical trial compared 4:3 fasting directly against continuous calorie restriction. At 12 months, the 4:3 group lost more weight than the daily-restriction group — a meaningful result because most fasting studies show similar, not superior, outcomes to standard dieting. This matters if you're already on a GLP-1 medication and wondering whether the pattern of when you cut calories makes a difference. The evidence suggests it might.

What the broader research shows

• Body composition matters, not just the scale. A scoping review of intermittent fasting in middle-aged and older adults found that preserving fat-free mass (muscle and bone) is a key concern with any fasting approach. Losing muscle alongside fat can slow your metabolism and reduce strength over time.

• Age may change your results. A systematic review and meta-analysis found that intermittent fasting affects body composition and cardiometabolic markers differently depending on age group (source). Older adults may need to pay extra attention to protein intake and resistance exercise alongside fasting.

• Fasting is being studied in complex populations. Researchers are now testing 4:3 fasting in groups like breast cancer survivors with overweight or obesity, signaling growing confidence in its safety profile — though results from those trials are still emerging.

What this means if you're on a GLP-1 medication

GLP-1 medications already reduce appetite and slow gastric emptying. Layering 4:3 fasting on top can amplify calorie reduction — but it also raises the importance of what you eat on non-fasting days. The research doesn't yet address the optimal fasting pattern specifically for GLP-1 users, so working with your healthcare team to personalize your approach is essential.

---

This content is for general informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your doctor or a qualified healthcare provider before starting or changing any fasting or dietary program, especially if you are taking prescription medications.

Will 4:3 fasting cause me to lose muscle?

Losing some muscle during any calorie-restricted diet is possible. Still, research suggests that 4:3 intermittent fasting is unlikely to cause significant muscle loss — especially when you eat enough protein and stay active on your non-fasting days.

What the research shows

A scoping review on intermittent fasting and fat-free mass found that intermittent fasting generally preserved fat-free mass (everything in your body that isn't fat, including muscle) in middle-aged and older adults, particularly when protein intake was adequate. This is encouraging for people combining fasting with GLP-1 medications, since GLP-1s already reduce appetite and calorie intake significantly.

A 12-month trial of 4:3 fasting found that participants lost meaningful body weight in a pattern consistent with fat loss rather than disproportionate muscle loss — a key distinction when evaluating any weight-loss approach.

A meta-analysis of intermittent fasting across age groups found that intermittent fasting did not cause greater muscle loss than continuous calorie restriction. In other words, fasting itself isn't uniquely harmful to muscle.

Factors that increase muscle-loss risk

• Very low protein intake: Protein is the building block of muscle. Eating too little — especially on fasting days — limits what your body has available to maintain muscle tissue.
• No resistance exercise: Strength training (lifting weights, resistance bands, bodyweight exercises) signals your body to preserve muscle even when calories are low.
• Rapid, extreme calorie restriction: The faster and deeper the calorie cut, the harder it is for your body to spare muscle.
• Older age: The scoping review noted that older adults may need extra attention to protein and exercise to maintain muscle during fasting.

How to protect your muscle

• Include a quality protein source (eggs, chicken, fish, legumes, Greek yogurt) at every meal on eating days.
• Do resistance exercise at least twice per week — even light bodyweight movements count.
• Talk to your care team about your protein target, as needs vary based on age, weight, and activity level.

---

This content is for general informational purposes only and is not a substitute for personalized medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional before starting or changing a fasting or exercise program, especially while taking a GLP-1 medication.

Who should be especially cautious about trying 4:3 fasting?

Several groups of people face meaningful risks with 4:3 fasting and should talk with their doctor before starting — or may need to avoid it entirely. This is especially true for people already taking a GLP-1 medication, since the combination of reduced appetite from the drug and structured fasting days can push calorie and nutrient intake very low.

⚠️ This content is for general information only and is not medical advice. Always consult a qualified healthcare provider before starting or changing any diet or medication plan.

---

People who should be especially cautious:

• Older adults (roughly 60+). Fasting can accelerate muscle loss — what researchers call fat-free mass — a risk that grows with age. A scoping review on intermittent fasting and fat-free mass found that middle-aged and older adults are particularly vulnerable to muscle loss during calorie-restricted fasting protocols. Since GLP-1 medications already reduce overall food intake, older adults on these drugs face compounded risk of losing muscle needed for strength, balance, and metabolism.

-People with a history of eating disorders. Structured fasting schedules that label days as "on" or "off" can trigger disordered thinking around food. The 4:3 feasibility trial in breast cancer survivors specifically flagged eating disorder history as a key safety screening criterion.

• People with depression or other mood conditions. Significant calorie restriction on fasting days can affect mood, energy, and motivation. A randomized controlled trial protocol studying intermittent fasting in people with major depression and obesity (source) treats this population as requiring careful monitoring because fasting and mood are closely linked.

• People with liver disease or significant cardiometabolic conditions. Fasting protocols interact with liver function and metabolic markers in ways that require medical supervision. The MEDFAST trial protocol highlights that people with liver fibrosis and cardiometabolic risk factors need structured clinical oversight when combining fasting with other interventions.

-Anyone with a history of low blood sugar (hypoglycemia). GLP-1 medications lower blood sugar independently. Adding fasting days on top of that — especially without adjusting medications — raises the risk of dangerously low blood sugar. Discuss this with your prescriber before your first fasting day.

• People who are pregnant, breastfeeding, or trying to conceive. Calorie restriction during these life stages carries well-established risks and is not appropriate without direct medical guidance.

If you fall into any of these groups, that doesn't automatically mean 4:3 fasting is off the table — but the decision belongs in a conversation with your care team, not a solo experiment.

Can digital tools and apps help me stick to a fasting plan?

Yes, digital tools and apps can meaningfully help you stick to a fasting plan — research shows that technology-based support improves engagement, self-monitoring, and weight-related outcomes for adults managing obesity.

A scoping review on digital obesity interventions found that integrating technology into care — through apps, wearables, and remote monitoring — supports adults in tracking behaviors and staying accountable over time. For people using GLP-1 medications alongside fasting, consistent tracking matters because GLP-1s (drugs like semaglutide or tirzepatide that reduce appetite by mimicking a natural gut hormone) already change hunger signals. An app can help you notice patterns you might otherwise miss.

What digital tools can realistically do:

• Track your eating window. Time-restricted eating is easier to maintain when an app reminds you when your window opens or closes. Several clinical trial protocols — including one studying time-restricted eating in people with depression and obesity — use app-based food logging as a core intervention component, suggesting researchers view it as a credible support tool.

• Log meals and nutrients. Because fasting alongside a GLP-1 medication can reduce overall intake, adequate protein becomes especially important for preserving muscle. A scoping review on intermittent fasting and muscle mass highlights that protein intake is a key variable worth monitoring — something a nutrition-tracking app can help you do daily.

• Support structured programs. Some clinical trials studying fasting schedules — such as the 4:3 plan (fasting three days per week, eating normally four days) — use digital tools to deliver coaching and collect data (source), suggesting apps can serve as a practical complement to professional support between appointments.

Important caveats:

• Apps vary widely in quality. Look for ones that let you log protein specifically, not just calories.
• No app replaces your healthcare team. Use digital tools to inform conversations with your provider, not to make medical decisions independently.
• Consistency matters more than perfection. Even simple check-ins — logging one meal, noting your energy level — build the self-awareness that makes fasting sustainable long-term.

---

This content is for general informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting or changing a fasting plan, especially if you are taking medication.

What should I discuss with my doctor before starting 4:3 fasting?

Before your first fasting day, bring a list of your current medications — especially your GLP-1 drug — to your doctor and ask how fasting will interact with your dose and schedule. That single conversation can prevent the most common and avoidable problems.

Why this conversation matters more when you're on a GLP-1

GLP-1 medications (drugs like semaglutide or tirzepatide that help control blood sugar and appetite) already reduce how much you want to eat. Layering 4:3 fasting — three non-consecutive fasting days per week — on top of that effect means your body is managing two appetite-suppressing forces at once. Your doctor needs the full picture to keep your plan safe and effective.

Specific things to discuss:

• Your medication timing and dose. Ask whether your injection or pill schedule needs to shift on fasting days. This is especially important if you also take insulin or other blood-sugar-lowering drugs, because combining them with fasting can raise the risk of low blood sugar (hypoglycemia — when blood sugar drops too low and causes shakiness, confusion, or fainting). The 4:3 trial researchers flagged medication management as a key safety checkpoint before participants began fasting.

• Your protein needs. Research on intermittent fasting in middle-aged and older adults shows that preserving lean muscle requires deliberate attention to protein intake, according to a scoping review. Ask your doctor or a registered dietitian how much protein you should aim for on both fasting and eating days.

• Any history of depression or mood concerns. Calorie restriction and fasting can affect mood. A clinical trial protocol studying fasting in people with depression and obesity specifically screens participants for mental health history before they begin, noting it as a relevant safety factor. Be honest with your provider about your mental health history.

• Existing liver or metabolic conditions. Fasting affects how the liver processes fat and sugar. A randomized trial studying fasting in people with cardiometabolic risk factors uses baseline liver testing before participants start, highlighting the importance of knowing your starting point.

• Cancer history or active treatment. A feasibility study of 4:3 fasting in breast cancer survivors requires medical clearance and close monitoring — a reminder that certain health histories call for extra caution.

Bring notes, ask questions, and don't start fasting days until you and your provider have a shared plan.

---

This content is for general information only and is not a substitute for personalized medical advice. Always consult a qualified healthcare professional before starting any fasting program or changing your medication routine.

FAQ

How is 4:3 fasting different from 5:2 fasting?

Both are forms of intermittent fasting that alternate normal eating days with restricted-calorie days. 4:3 fasting involves three fasting or very-low-calorie days per week rather than two, which some researchers believe may produce a larger weekly calorie deficit. A 2025 trial in Annals of Internal Medicine specifically studied the 4:3 pattern and found it outperformed daily calorie restriction for weight loss at 12 months (PMID 42296520). Still, individual results vary, and no outcome is guaranteed.

Does intermittent fasting affect gut health?

Some research, including a study on Ramadan intermittent fasting, suggests that periodic fasting may influence gut microbiome diversity and composition in ways that could relate to metabolic health (PMID 42293192). However, this is an active area of research, and it is not yet clear how findings from religious fasting translate to structured 4:3 protocols.

Is 4:3 fasting safe for older adults?

A scoping review of intermittent fasting studies in middle-aged and older adults found that fat-free mass was generally maintained. However, outcomes varied depending on the specific fasting protocol and the individual (PMID 42463249). An age-specific meta-analysis also found cardiometabolic benefits across age groups (PMID 42280443). Older adults should consult a healthcare provider before starting any fasting regimen, particularly if they take medications or have chronic conditions.

Can people with depression try intermittent fasting?

Researchers are currently running a randomized controlled trial to investigate whether time-restricted eating, with or without calorie restriction, affects depression scores and metabolic factors in people with major depressive disorder and obesity (PMID 42363285). Because this evidence is still being gathered, anyone with a mood disorder should speak with a mental health professional and physician before attempting a fasting protocol.

What is early time-restricted eating and how does it differ from standard 4:3 fasting?

Early time-restricted eating (eTRE) limits the daily eating window to earlier hours—for example, finishing the last meal by early afternoon. A clinical trial called MEDFAST is comparing an eTRE Mediterranean diet approach to medication for liver fibrosis in people with cardiometabolic risk factors (PMID 42350004). This differs from 4:3 fasting, which focuses on which days calories are restricted rather than what time of day eating occurs.

How can I track my fasting progress?

A scoping review of digital health interventions for obesity management found that apps, wearables, and online platforms are increasingly used to support dietary tracking and behavior change. However, the long-term effectiveness of these tools is still being studied (PMID 42310647). Digital tools may help with logging meals and fasting windows, but they are not a substitute for professional guidance.

This article is for general information and is not medical advice. GLP-1 medications are prescription drugs, and fasting is not right for everyone — talk to a licensed healthcare provider before starting, stopping, or changing any treatment or eating pattern.